Table 2.

Echocardiography and Cardiac Magnetic Resonance Imaging in the Prospective Cohort (n=75)

	Total	hs‐TNT <5 ng/L	hs‐TNT 5 to 14 ng/L	hs‐TNT >14 ng/L
	n=75	n=29	n=16	n=30
Echocardiography
LV end‐diastolic dimension, mm	47±6	47±5	45±6	48±7
IVSd, mm	10.2±2.5	8.2±1.4	9.9±1.7*	12.2±2.1*, †
LVPWd, mm	10.0±2.3	8.3±1.3	9.8±1.5*	11.7±2.1*, †
LV fractional shortening, mm	36±7	35±8	39±6	35±6
End‐diastolic LV volume, mL	107±32	110±22	93±28	111±39
End‐systolic LV volume, mL	38±18	40±15	30±12	41±21
Stroke volume, mL	69±21	69±17	64±21	71±26
LV mass index, g/m²	96±43	91±38	96±36	102±51
Left atrial diameter, mm	35±5	33±4	35±3	38±5*, †
LVEF, %	65±6	64±6	65±6	66±6
E/A	1.5±0.6	1.5±0.5	1.4±0.5	1.6±0.7
E/E′	10.4±4.6	7.0±1.8	9.7±2.6*	13.9±4.8*, †
DT, ms	208±49	201±56	207±37	216±49
SPAP, mm Hg	25±6	24±5	25±5	27±7
Magnetic resonance imaging
LE positive, n (%)	34 (45.3)	1 (3.4)	4 (25.0)	29 (96.7)
LE‐positive myocardial volume, %	0 (0–8.5)	0 (0–0.71)	0 (0–1.2)*	1.4 (0–8.5)*, †
LVMI, g/m²	88±36	69±19	79±24	111±41*, †
End‐diastolic LV volume, mL	142±45	140±37	130±31	150±57
End‐systolic LV volume, mL	51±24	55±21	39±13	55±29
Stroke volume, mL	92±25	91±23	92±22	93±28
LVEF, %	66±10	64±8	70±6	65±13

DT indicates deceleration time of early filling; E/A, early diastolic filling velocity (E) to late diastolic filling velocity (A) ratio; E/E′, mitral inflow velocity (E) to tissue Doppler E′ ratio; hs‐TNT, high‐sensitivity cardiac troponin T; IVSd, end‐diastolic interventricular septal wall thickness; LE, late enhancement; LV, left ventricle; LVEF, LV ejection fraction; LVMI, LV mass indexed to body surface area; LVPWd, end‐diastolic posterior wall thickness; SPAP, systolic pulmonary artery pressure.

*P<0.05 vs hs‐TNT <5 ng/L.

^† P<0.05 vs hs‐TNT 5 to 14 ng/L.